Riskpilot← Back to searchSign inGet full accessScara Supplements & Consulting AB
ABActiveOrg 5569928616Removal services · NACE 4942Est. 20147 employees
Revenue 2024
SEK 619K
EBITDA margin
18.6%
Equity ratio
-79.6%
Financial strength
Net profit 2024
SEK 49K
7 employees
| Revenue | SEK 619K | — |
| EBITDA | SEK 115K | — |
| Net profit | SEK 49K | — |
| Total assets | SEK 181K | — |
| Equity | SEK -144K | — |
| Employees | 7 | — |
Legal name
Scara Supplements & Consulting AB
Org number
5569928616
Legal form
Aktiebolag
NACE code
4942 · Removal services
Founded
1 december 2014
Share capital
SEK 50 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget bedriva import och försäljning av kosttillskott, hälsorelaterad utrustning, lagerhållning och transport. Vidare ska bolaget bedriva rådgivning och coachning. Utöver det ska verksamheten bedriva insatser inom lagrum såsom Socialtjänstlag och LSS, där daglig verksamhet och meningsfull sysselsättning ska främjas. Därmed förenlig verksamhet.
Address
Email
kenny.sydhagen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 2 104 | 2 018 | — | 619 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 183 | −31 | 0 | 115 |
| Depreciation & amort. | — | −38 | −0 | — | −30 |
| EBIT | 0 | 145 | −31 | 0 | 85 |
| Net financials | — | −6 | −27 | — | −22 |
| Profit before tax | 0 | 104 | −19 | 0 | 63 |
| Tax | — | −22 | −0 | — | −14 |
| Net profit | — | 82 | −19 | — | 49 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 150 | 321 | — | 181 |
| Equity | — | −104 | −123 | — | −144 |
| Long-term debt | — | 0 | 0 | — | 0 |
| Short-term debt | — | 170 | 394 | — | 275 |
| Total debt | — | 170 | 394 | — | 275 |
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
20202024
Equity ratio
-79.6%
This company
38.2%
Market median
-308% vs market
20202024
Return on equity
4900000.0%
This company
18.4%
Market median
+26630335% vs market
20202024
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20202024
Asset turnover
3.42×
This company
1.12×
Market median
+205% vs market
20202024
Debt / equity
2.26×
This company
0.62×
Market median
-265% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Scara Supplements & Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Kenny Sydhagen | Chairman | 0 companies |
| Karin Maria Elisabet Sydhagen | Board of Directors | 0 companies |
| Anette Yvonne Irene Björkensköld | Deputy Board Member | 0 companies |